Atlas Trials

Lanreotide in the Treatment of Small Bowel Motility Disorders

Clinical trial NCT03012594 · COMPLETED

Trial details

NCT number
NCT03012594
Sponsor
Northwell Health
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Gastrointestinal Motility DisorderIntestinal Disease
Start date
2017-05-11
Primary completion
2018-10-21
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.